Literature DB >> 31258140

Changing patterns of upper gastrointestinal bleeding over 23 years in Turkey.

Nilay Danış1, Fatih Tekin1, Ulus Salih Akarca1, Nalan Gülsen Ünal1, Elvan Işık Erdoğan1, Kıvanç Akat1, Ümit Demirkoparan1, Zeki Karasu1, İlker Turan1, Nevin Oruç1, Ahmet Aydın1, Galip Ersöz1, Rukiye Vardar1, Ömer Özütemiz1, Fulya Günşar1.   

Abstract

BACKGROUND/AIMS: This study aimed to compare the causes of nonvariceal upper gastrointestinal bleeding (NVUGB), demographics, risk factors, and outcomes of patients during two periods between 1993 and 2016 in a tertiary health-care center in Turkey.
MATERIALS AND METHODS: We compared the causes of NVUGB and clinical outcomes in 421 patients hospitalized between January 1993 and December 1995 with those of 231 patients with NVUGB hospitalized between January 2015 and September 2016. We also compared epidemiological characteristics, risk factors, and the rates of endoscopic hemostatic procedures.
RESULTS: We observed significant increases in patients' mean age, in the percentage of patients with comorbid conditions, and in the percentage of patients who received direct-acting oral anticoagulants before bleeding. We also observed a statistically nonsignificant increase in the diagnoses of gastric ulcer, along with a significant concordant decrease in diagnoses of duodenal ulcer as a cause of bleeding. The use of emergency surgical hemostasis decreased among cases of peptic ulcer bleeding. The overall rate of mortality from bleeding did not significantly change between the two periods.
CONCLUSION: Over the 23 years studied, the causes of NVUGB changed, probably because the population was increasingly elderly population and because of the use of anticoagulants and better therapeutic approaches to chronic duodenal ulcers. The use of emergency surgical hemostasis reduced, but mortality rate did not significantly change between the two specific periods.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31258140      PMCID: PMC6812949          DOI: 10.5152/tjg.2019.19239

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  18 in total

Review 1.  Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding.

Authors:  Thomas Tielleman; Daniel Bujanda; Byron Cryer
Journal:  Gastrointest Endosc Clin N Am       Date:  2015-07

2.  Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Authors:  John W Eikelboom; Lars Wallentin; Stuart J Connolly; Mike Ezekowitz; Jeff S Healey; Jonas Oldgren; Sean Yang; Marco Alings; Scott Kaatz; Stefan H Hohnloser; Hans-Christoph Diener; Maria Grazia Franzosi; Kurt Huber; Paul Reilly; Jeanne Varrone; Salim Yusuf
Journal:  Circulation       Date:  2011-05-16       Impact factor: 29.690

3.  The changing face of hospitalisation due to gastrointestinal bleeding and perforation.

Authors:  A Lanas; L A García-Rodríguez; M Polo-Tomás; M Ponce; E Quintero; M A Perez-Aisa; J P Gisbert; L Bujanda; M Castro; M Muñoz; M D Del-Pino; S Garcia; X Calvet
Journal:  Aliment Pharmacol Ther       Date:  2011-01-05       Impact factor: 8.171

Review 4.  Bleeding peptic ulcer.

Authors:  L Laine; W L Peterson
Journal:  N Engl J Med       Date:  1994-09-15       Impact factor: 91.245

5.  Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.

Authors:  Antonio L Dans; Stuart J Connolly; Lars Wallentin; Sean Yang; Juliet Nakamya; Martina Brueckmann; Michael Ezekowitz; Jonas Oldgren; John W Eikelboom; Paul A Reilly; Salim Yusuf
Journal:  Circulation       Date:  2012-12-27       Impact factor: 29.690

6.  Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.

Authors:  Esther W Chan; Wallis C Y Lau; Wai K Leung; Michael T C Mok; Ying He; Teresa S M Tong; Ian C K Wong
Journal:  Gastroenterology       Date:  2015-05-08       Impact factor: 22.682

7.  Nonvariceal upper gastrointestinal bleeding in elderly people: Clinical outcomes and prognostic factors.

Authors:  José A González-González; Roberto Monreal-Robles; Diego García-Compean; Jonathan Paz-Delgadillo; Martín Wah-Suárez; Héctor J Maldonado-Garza
Journal:  J Dig Dis       Date:  2017-04       Impact factor: 2.325

8.  Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding.

Authors:  Kristina Ahsberg; Peter Höglund; Won-Hie Kim; Christer Staël von Holstein
Journal:  Scand J Gastroenterol       Date:  2010-08-09       Impact factor: 2.423

9.  Favorable prognosis of upper-gastrointestinal bleeding in 1041 older patients: results of a prospective multicenter study.

Authors:  Stéphane Nahon; Olivier Nouel; Herve Hagège; Philippe Cassan; Alexandre Pariente; Remi Combes; Alain Kerjean; Sylva Doumet; Perrine Cocq-Vezilier; Guillaume Tielman; Thierry Paupard; Eric Janicki; David Bernardini; Michel Antoni; Jajjia Haioun; Didier Pillon; Philippe Bretagnolle
Journal:  Clin Gastroenterol Hepatol       Date:  2008-06-04       Impact factor: 11.382

Review 10.  Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.

Authors:  Ka-Shing Cheung; Wai K Leung
Journal:  World J Gastroenterol       Date:  2017-03-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.